EVALUATION OF A MONOCLONAL ANTIBODY

NIH RePORTER · NIH · N01 · $843,463 · view on reporter.nih.gov ↗

Abstract

The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes.

Key facts

NIH application ID: 10683485
Project number: 272201600005I-0-759302200001-1
Recipient: DYNPORT VACCINE COMPANY, LLC
Principal Investigator: MARY KATE HART
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $843,463
Award type: —
Project period: 2022-07-20 → 2023-01-19